EPCAM and cancer: Organoid targeting was studied with NK-92 cells expressing CAR for the epithelial cell adhesion molecule (EPCAM), the neoantigen EGFRvIII found in several cancers, or the Frizzled receptor upregulated in some CRC patients [232].